Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From Immune Microenvironment Characterization and Gene Expression Profiling to New Drugs Testing in Pleural and Peritoneal Mesothelioma: Imaging-Meso Study

NCT06581549 is registered in ClinicalTrials.gov with Istituto Oncologico Veneto IRCCS as lead sponsor.

NCT NCT06581549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From Immune Microenvironment Characterization and Gene Expression Profiling to New Drugs Testing in Pleural and Peritoneal Mesothelioma: Imaging-Meso Study
Lead sponsor
Istituto Oncologico Veneto IRCCS
Phase
Observational
Overall status
Completed
Start date
November 2, 2023
Completion date
August 5, 2026
Enrollment
125 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma, mesothelioma; lung, mesotheliomas pleural